Influenza Economics Assessments
National governments require economic data on the burden of influenza disease, the cost effectiveness of the vaccine, and the projected implementation costs of a maternal influenza immunization programme in their country in order to inform the allocation of limited resources and prioritization of interventions in the health sector. To support decision making and implementation efforts in countries, WHO has developed the Economic Value Chain for Influenza Vaccination.
WHO offers a Manual for Estimating Disease Burden Associated With Seasonal Influenza to countries. With disease burden estimates established, the below resource documents can then support the assessment of the economic and social benefits of introducing influenza vaccination or to expand existing vaccination strategies.
For further information on the use of and access to the below tools please contact: influenzavaccine@who.int